Abstract:Platelet transfusions carry greater risks of infection, sepsis, and death than any other blood product, owing primarily to bacterial contamination. Many patients may be at particular risk, including critically ill patients in the intensive care unit. This narrative review provides an overview of the problem and an update on strategies for the prevention, detection, and reduction/inactivation of bacterial contaminants in platelets. Bacterial contamination and septic transfusion reactions are major sources of morbidity and mortality. Between 1:1000 and 1:2500 platelet units are bacterially contaminated. The skin bacterial microflora is a primary source of contamination, and enteric contaminants are rare but may be clinically devastating, while platelet storage conditions can support bacterial growth. Donor selection, blood diversion, and hemovigilance are effective but have limitations. Biofilm-producing species can adhere to biological and non-biological surfaces and evade detection. Primary bacterial culture testing of apheresis platelets is in routine use in the US. Pathogen reduction/inactivation technologies compatible with platelets use ultraviolet light-based mechanisms to target nucleic acids of contaminating bacteria and other pathogens. These methods have demonstrated safety and efficacy and represent a proactive approach for inactivating contaminants before transfusion to prevent transfusion-transmitted infections. One system, which combines ultraviolet A and amotosalen for broad-spectrum pathogen inactivation, is approved in both the US and Europe. Current US Food and Drug Administration recommendations advocate enhanced bacterial testing or pathogen reduction/inactivation strategies (or both) to further improve platelet safety. Risks of bacterial contamination of platelets and transfusion-transmitted infections have been significantly mitigated, but not eliminated, by improvements in prevention and detection strategies. Regulatory-approved technologies for pathogen reduction/inactivation have further enhanced the safety of platelet transfusions. Ongoing development of these technologies holds great promise.

Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine

Operational feasibility of routine bacterial monitoring of platelets

Detection of bacteria in platelet concentrates prepared from spiked single donations using cultural and molecular genetic methods

Three Different Bacterial Detection Systems for Platelet Concentrates under Inter-Laboratory Conditions.

Screening of platelets for bacterial contamination at the Welsh Blood Service

Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system

Routine bacterial screening of platelet concentrates by flow cytometry and its impact on product safety and supply

Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism

The use of a chemiluminescence‐linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell‐reduced and nonreduced platelets

The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update

Bacterial contamination of platelets concentrates in a lower middle-income country: Data from a single tertiary care hospital

Bacterial Detection of Platelets: Current Problems and Possible Resolutions

Evaluation of the value of anaerobic culture in bacterial contamination forapheresis platelets

Detection of Bacterial Contamination of Apheresis Platelets in a Chinese Blood Center

Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories

Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure

The operational and financial impact of adding anaerobic screening of platelets

Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results

Bacterial Contamination of Platelet Products

Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction

Bacterial contamination of platelets for transfusion: strategies for prevention